Lista de obras -

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

artículo científico publicado en 2018

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.

artículo científico publicado en 2017

A randomized phase II study of low-dose decitabine versus low-dose azacitidine in lower risk MDS and MDS/MPN.

artículo científico publicado en 2017

AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth

artículo científico publicado en 2017

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse

artículo científico publicado en 2008

Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells

artículo científico publicado en 2015

Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features

artículo científico publicado en 2015

Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation

artículo científico

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center

artículo científico publicado en 2005

Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia

artículo científico publicado en 2009

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

artículo científico publicado en 2010

An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes

artículo científico publicado en 2017

Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia

artículo científico publicado en 2008

Analysis of class I and II histone deacetylase gene expression in human leukemia

artículo científico

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.

artículo científico publicado en 2014

BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias

artículo científico publicado en 2008

Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome

artículo científico publicado en 2015

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

artículo científico publicado en 2017

CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias

artículo científico publicado en 2013

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations

artículo científico publicado en 2018

Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma.

artículo científico publicado en 2017

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia

artículo científico publicado en 2010

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

artículo científico publicado en 2006

Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia

artículo científico publicado en 2017

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia

artículo científico publicado en 2018

Clinical Outcomes and Influence of Mutation Clonal Dominance in Oligomonocytic and Classical Chronic Myelomonocytic Leukemia

artículo científico publicado en 2020

Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia

artículo científico publicado en 2013

Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

artículo científico publicado en 2014

Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents

artículo científico publicado en 2016

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

artículo científico publicado en 2020

Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment

artículo científico publicado en 2013

Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3 ⬇️

artículo científico publicado el 5 de julio de 2011

Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission ⬇️

artículo científico publicado el 17 de junio de 2013

Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis

artículo científico publicado en 2009

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease

scientific article published on 07 May 2019

DNA methylation patterns at relapse in adult acute lymphocytic leukemia

artículo científico publicado en 2002

Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase

artículo científico publicado en 2011

Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia

artículo científico publicado en 2012

Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers

artículo científico publicado en 2013

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study

artículo científico publicado en 2018

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.

artículo científico publicado en 2017

Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia

artículo científico publicado en 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation

artículo científico publicado en 2017

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

artículo científico publicado en 2010

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

artículo científico publicado en 2020

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia

artículo científico publicado en 2007

HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target

artículo científico publicado en 2006

High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

artículo científico publicado en 2016

High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia

artículo científico publicado en 2010

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

artículo científico publicado en 2017

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience

artículo científico publicado en 2006

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia

artículo científico publicado en 2015

Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001

artículo científico publicado en 2009

Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia

artículo científico publicado en 2004

Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents

artículo científico publicado en 2017

Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes

artículo científico publicado en 2014

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

artículo científico publicado en 2018

Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers ⬇️

artículo científico publicado el 25 de agosto de 2011

Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes

artículo científico publicado en 2018

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

scientific article published on 29 April 2019

Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

artículo científico publicado en 2016

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

artículo científico publicado en 2005

KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice

artículo científico publicado en 2018

Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia

artículo científico publicado en 2008

Kit inhibitor APcK110 extends survival in an AML xenograft mouse model

artículo científico publicado en 2010

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?

scholarly article by Musa Yilmaz et al published 16 January 2019 in Blood Cancer Journal

Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis

artículo científico publicado en 2009

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis

artículo científico publicado en 2018

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy

artículo científico publicado en 2013

MYC protein expression is an important prognostic factor in acute myeloid leukemia

artículo científico publicado en 2018

Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias

artículo científico publicado en 2010

Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia

artículo científico publicado en 2012

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.

artículo científico publicado en 2017

Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable

artículo científico publicado en 2018

Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.

artículo científico publicado en 2016

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents

artículo científico publicado en 2017

Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome

artículo científico publicado en 2011

Outcome of patients with acute myelogenous leukemia after second salvage therapy

artículo científico publicado en 2005

Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy

scientific article published on 28 February 2020

Patient with mixed-phenotype acute leukemia with CBFB rearrangement

scientific article published on 23 April 2019

Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies

artículo científico publicado en 2008

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

artículo científico publicado en 2006

Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents

artículo científico publicado en 2016

Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation

scientific article published on 14 September 2018

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

artículo científico publicado en 2015

Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes

artículo científico publicado en 2014

Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system

artículo científico publicado en 2012

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

artículo científico

Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation

artículo científico publicado en 2006

Prognostic impact of RAS mutations in patients with myelodysplastic syndrome

artículo científico publicado en 2013

Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis

artículo científico publicado en 2013

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

artículo científico publicado en 2016

Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104

artículo científico publicado en 2011

Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

artículo científico publicado en 2020

RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype

artículo científico publicado en 2015

Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients

artículo científico publicado en 2010

Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay

artículo científico publicado en 2012

Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia

artículo científico publicado en 2008

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

artículo científico publicado en 2006

Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.

artículo científico publicado en 2018

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

artículo científico publicado en 2016

Rituximab in relapsed or refractory hairy cell leukemia

artículo científico publicado en 2003

STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis

artículo científico publicado en 2014

Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study

scientific article published on 22 December 2014

Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy

artículo científico publicado en 2005

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

artículo científico publicado en 2022

Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience

artículo científico publicado en 2007

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

artículo científico publicado en 2015

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens

artículo científico publicado en 2015

Targeting neuropilin-1 in human leukemia and lymphoma

artículo científico publicado en 2011

Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome

artículo científico publicado en 2015

The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia

artículo científico publicado en 2013

The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes

artículo científico publicado en 2013

The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy

artículo científico publicado en 2005

The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

artículo científico publicado en 2018

The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?

artículo científico publicado en 2009

The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms

artículo científico publicado en 2008

The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma

artículo científico publicado en 2002

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

artículo científico publicado en 2015

Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis

scientific article published on 15 November 2018

Lista de obras de

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.

A randomized phase II study of low-dose decitabine versus low-dose azacitidine in lower risk MDS and MDS/MPN.

AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse

Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells

Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features

Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center

Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes

Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia

Analysis of class I and II histone deacetylase gene expression in human leukemia

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.

BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias

Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations

Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma.

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia

Clinical Outcomes and Influence of Mutation Clonal Dominance in Oligomonocytic and Classical Chronic Myelomonocytic Leukemia

Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia

Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment

Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3 ⬇️

Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission ⬇️

Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease

DNA methylation patterns at relapse in adult acute lymphocytic leukemia

Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase

Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia

Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.

Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia

HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target

High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia

Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001

Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia

Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents

Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers ⬇️

Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice

Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia

Kit inhibitor APcK110 extends survival in an AML xenograft mouse model

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?

Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy

MYC protein expression is an important prognostic factor in acute myeloid leukemia

Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias

Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.

Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable

Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents

Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome

Outcome of patients with acute myelogenous leukemia after second salvage therapy

Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy